Phillips 66 vs Sanofi
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Phillips 66
$96.0B
μμ #169
Sanofi
$99.2B
μμ #165
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ°λλ³ λΉκ΅
| μ°λ | Phillips 66 | Sanofi | μ λ |
|---|---|---|---|
| 2026 | $96.0B | $99.2B | Sanofi |
| 2025 | $50.9B | $101.3B | Sanofi |
| 2024 | $43.4B | $109.9B | Sanofi |
| 2023 | $49.1B | $101.1B | Sanofi |
| 2022 | $36.9B | $97.5B | Sanofi |
| 2021 | $24.6B | $92.4B | Sanofi |
| 2020 | $22.7B | $79.1B | Sanofi |
| 2019 | $34.3B | $86.8B | Sanofi |
| 2018 | $25.6B | $70.3B | Sanofi |
| 2017 | $29.2B | $63.7B | Sanofi |
| 2016 | $24.2B | $66.0B | Sanofi |
| 2015 | $22.2B | $64.7B | Sanofi |
| 2014 | $18.9B | $60.3B | Sanofi |
| 2013 | $19.9B | $59.3B | Sanofi |
| 2012 | $13.4B | $53.1B | Sanofi |